Company / Operating Income
Arcturus Therapeutics Holdings Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$76.3M
FY2025
5-year range
-$202.9M / -$76.3M
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$78M to -$76M over the past 2 years.
Based on SEC 10-K filings.
-$76M in FY2025.
Improved from -$78M to -$76M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 20.3% year-over-year.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$76.3M | +20.3% |
| FY2024 | -$95.7M | -22.3% |
| FY2023 | -$78.2M | +61.4% |
| FY2022 | -$202.9M | +0.0% |
| FY2021 | -$202.9M | -830.0% |
| FY2020 | -$21.8M | +0.0% |
| FY2019 | -$21.8M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026